Live Breaking News & Updates on Phd Lambe Institute For Translational Medicine

Stay updated with breaking news from Phd lambe institute for translational medicine. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Latest TAVI vs Surgery Trial Raises Eyebrows in Aortic Stenosis Plus CAD

Latest TAVI vs Surgery Trial Raises Eyebrows in Aortic Stenosis Plus CAD
tctmd.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tctmd.com Daily Mail and Mail on Sunday newspapers.

University Hospital , New York , United States , France General , Elvin Kedhi , Gilbert Tang , Jean Fajadet , Hendrik Treede , William Wijns , Clinique Pasteur , Md University Hospital , Phd Victoria Hospital Mcgill University , Md Mount Sinai Health System , Phd Lambe Institute For Translational Medicine , Transcatheter Valves , Victoria Hospital Mcgill University , Directors William Wijns , Lambe Institute , Translational Medicine , Mount Sinai Health System , European Society , European Association , Cardiothoracic Surgery ,

FUTURE II: A Good 'First Step' for Thinner-Strut Bioresorbable Scaffold

May 19, 2021
A new bioresorbable scaffold (Firesorb, MicroPort Medical), one with much thinner struts compared with first-generation “dissolving” devices, has shown some early promise in a study of patients with relatively simple coronary artery lesions.
Presenting the results of FUTURE II as a late-breaking clinical trial at EuroPCR, Bo Xu, MBBS (National Clinical Research Center for Cardiovascular Disease/Peking Union Medical College, Beijing, China), reported that in this trial, which included operators adhering to a dedicated implantation technique, the bioresorbable scaffold was noninferior to a cobalt-chromium everolimus-eluting stent (Xience; Abbott Vascular) for the primary endpoint of in-segment late lumen loss.
While FUTURE II is a small study looking solely at angiographic outcomes, Xu said he remains optimistic about the technology. “I think, although this is a very small sized study with angiographic outcomes is comparing a new device with a drug ....

New York , United States , Bo Xu , William Wijns , National Clinical Research Center , Phd Lambe Institute For Translational Medicine , National University Of Ireland Galway , Cardiovascular Disease Peking Union Medical College , Microport Medical , Peking Union Medical College , Abbott Vascular , Icahn School , Mount Sinai , Old Is New , Mean In Segment Late , Lambe Institute , Translational Medicine , National University , Ireland Galway , புதியது யார்க் , ஒன்றுபட்டது மாநிலங்களில் , போ ஐயூ , தேசிய மருத்துவ ஆராய்ச்சி மையம் , ஃப்ட் ஆட்டுக்குட்டி நிறுவனம் க்கு மொழிபெயர்ப்பு மருந்து , தேசிய பல்கலைக்கழகம் ஆஃப் ஐயர்ல்யாஂட் கால்வே , பேகிங் தொழிற்சங்கம் மருத்துவ கல்லூரி ,